Paper42945342PubMed
MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation.
Qi X and 17 others. PLoS Pathog, 2026.
Cite this record
ConductScience Library. MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation. Papers, record 42945342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42945342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MARK3 promotes host antiviral defense by driving GEF-H1-mediated TBK1 activation.
- Journal
- PLoS Pathog
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-29
Source PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Serine-Threonine Kinases | Major topic |
| Immunity, Innate | Major topic |
| Rho Guanine Nucleotide Exchange Factors | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Phosphorylation | |
| Interferon Regulatory Factor-3 | |
| Signal Transduction | |
| Interferon Type I |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33328453 | Genetic architecture of host proteins involved in SARS-CoV-2 infection. | Nat Commun | 2020 | https://conductscience.org/library/papers/33328453 | PubMed |
| 2 | 11741534 | C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. | Mol Cell | 2001 | https://conductscience.org/library/papers/11741534 | PubMed |
| 3 | 24533944 | MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies. | Acta Neuropathol Commun | 2014 | https://conductscience.org/library/papers/24533944 | PubMed |
| 4 | 18394899 | Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis? | Trends Cell Biol | 2008 | https://conductscience.org/library/papers/18394899 | PubMed |
| 5 | 32075101 | Microtubule-Mediated NLRP3 Inflammasome Activation Is Independent of Microtubule-Associated Innate Immune Factor GEF-H1 in Murine Macrophages. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32075101 | PubMed |
| 6 | 19120477 | Innate immunity to virus infection. | Immunol Rev | 2009 | https://conductscience.org/library/papers/19120477 | PubMed |
| 7 | 35681428 | Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease. | Cells | 2022 | https://conductscience.org/library/papers/35681428 | PubMed |
| 8 | 15827085 | PAK4 mediates morphological changes through the regulation of GEF-H1. | J Cell Sci | 2005 | https://conductscience.org/library/papers/15827085 | PubMed |
| 9 | 36113429 | Actin cytoskeleton remodeling primes RIG-I-like receptor activation. | Cell | 2022 | https://conductscience.org/library/papers/36113429 | PubMed |
| 10 | 18287519 | GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA. | Mol Biol Cell | 2008 | https://conductscience.org/library/papers/18287519 | PubMed |
| 11 | 36384137 | AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity. | Mol Cell | 2022 | https://conductscience.org/library/papers/36384137 | PubMed |
| 12 | 14976552 | LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. | EMBO J | 2004 | https://conductscience.org/library/papers/14976552 | PubMed |
| 13 | 26235147 | STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/26235147 | PubMed |
| 14 | 17488622 | GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. | Dev Cell | 2007 | https://conductscience.org/library/papers/17488622 | PubMed |
| 15 | 16125763 | Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. | Cell | 2005 | https://conductscience.org/library/papers/16125763 | PubMed |
| 16 | 28783414 | Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages. | Cell Cycle | 2017 | https://conductscience.org/library/papers/28783414 | PubMed |
| 17 | 17483521 | Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17483521 | PubMed |
| 18 | 11433294 | PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11433294 | PubMed |
| 19 | 17699722 | CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. | Mol Cancer Ther | 2007 | https://conductscience.org/library/papers/17699722 | PubMed |
| 20 | 11912491 | Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. | Nat Cell Biol | 2002 | https://conductscience.org/library/papers/11912491 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42945342
GET https://conductscience.org/api/papers/v1/42945342/references?page=2